Zoetis (ZTS) Operating Expenses (2012 - 2026)
Zoetis' (ZTS) quarterly Operating Expenses came in at $788.0 million in Q1 2026, up 7.07% year-on-year from $736.0 million in Q1 2025, and down 5.52% on a QoQ basis from $834.0 million in Q4 2025.
Zoetis (ZTS) Operating Expenses (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Operating Expenses data on file, last reported at $788.0 million in Q1 2026.
- On a quarterly basis, Operating Expenses rose 7.07% year-over-year to $788.0 million in Q1 2026; TTM through Mar 2026 was $3.2 billion, a 3.7% increase from a year earlier, with the FY2025 full-year figure at $3.1 billion, up 2.22% from the prior year.
- Operating Expenses for Q1 2026 stood at $788.0 million, down from $834.0 million in the prior quarter.
- Over the last five years, Operating Expenses for ZTS reached as high as $834.0 million in Q4 2025 and fell as low as $589.0 million in Q1 2022.
- Historically, Operating Expenses has averaged $727.0 million across 5 years, with a median of $736.0 million in 2025.
- On a YoY basis, Operating Expenses climbed as much as 349.62% in 2022 and fell as far as 10.34% in 2022.
- Year by year, Operating Expenses stood at $659.0 million in 2022, then increased by 13.35% to $747.0 million in 2023, then climbed by 8.84% to $813.0 million in 2024, then increased by 2.58% to $834.0 million in 2025, then declined by 5.52% to $788.0 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $788.0 million in Q1 2026, $834.0 million in Q4 2025, and $753.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 455.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 50.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 788.00 Mn |
| Dec 31, 2025 | 834.00 Mn |
| Sep 30, 2025 | 753.00 Mn |
| Jun 30, 2025 | 819.00 Mn |
| Mar 31, 2025 | 736.00 Mn |
| Dec 31, 2024 | 813.00 Mn |
| Sep 30, 2024 | 737.00 Mn |
| Jun 30, 2024 | 794.00 Mn |
| Mar 31, 2024 | 713.00 Mn |
| Dec 31, 2023 | 747.00 Mn |
| Sep 30, 2023 | 693.00 Mn |
| Jun 30, 2023 | 710.00 Mn |
| Mar 31, 2023 | 668.00 Mn |
| Dec 31, 2022 | 659.00 Mn |
| Sep 30, 2022 | 641.00 Mn |
| Jun 30, 2022 | 665.00 Mn |
| Mar 31, 2022 | 589.00 Mn |
| Dec 31, 2021 | 735.00 Mn |
| Sep 30, 2021 | 645.00 Mn |
| Jun 30, 2021 | 636.00 Mn |